The Swiss Connection

Why Are leading Swiss Pharmaceutical Companies Investing in Slovenia?

SWI swissinfo.ch Season 2 Episode 6

Send us a text

Pharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production.  Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines.

Articles and videos on Switzerland's investment in Slovenia are available on swissinfo.ch. For other science stories from Switzerland please go to www.swissinfo.ch/science.

Journalist: Jessica Davis Plüss
Host: Jo Fahy
Audio editor/video journalist: Céline Stegmüller & Michele Andina
Distribution and Marketing: Xin Zhang

SWI swissinfo.ch is a public service media company based in Bern, Switzerland.

People on this episode

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.

Inside Geneva Artwork

Inside Geneva

SWI swissinfo.ch
Dangereux Millions Artwork

Dangereux Millions

SWI swissinfo.ch - Europe 1 Studio - Gotham City
O Sequestro da Amarelinha Artwork

O Sequestro da Amarelinha

revista piauí, Swissinfo e Rádio Novelo
Lost Cells Artwork

Lost Cells

SWI swissinfo.ch
Madre Célula Artwork

Madre Célula

SWI swissinfo.ch
Cellules Perdues Artwork

Cellules Perdues

SWI swissinfo.ch